CVS Health Corporation CVS

Set alert

Price alert · CVS

All alert types
88.51 USD 0.00 0.00%

At close

88.40 -0.11 -0.12%

Pre-market · Nov 3, 9:14 AM ET

Bid
88.51 × 1,000
Ask
88.52 × 200

Day range unavailable

69.51 52-week range 110.68
YTD
+11.53%
1 year
+12.84%
Open
—
Prev close
88.51
Mkt cap
113.20B
Vol
0
Avg vol
8.03M
EPS
3.80
P/E
23.29
Div yield
2.94%
More statistics
Low
—
High
—
Forward P/E
10.37
Beta
0.58
Short ratio
1.63
Inst. own
90.99%
Dividend
2.66
Ex-div date
Oct 21, 2026
Earnings
Nov 4, 2026
50-d avg
91.23
200-d avg
88.79
1y target
115.48

30m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (17)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM17 hours ago
MACD: Buy SignalNov 2, 2:55 PM18 hours ago
SMA: BullishNov 2, 2:25 PM19 hours ago
RSI: OversoldNov 2, 10:55 AM22 hours ago
MACD: Sell SignalNov 2, 9:55 AM23 hours ago
RSI: OversoldNov 2, 9:55 AM23 hours ago
SMA: BearishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:25 PM3 days ago
SMA: BullishOct 30, 10:55 AM3 days ago
SMA: BearishOct 30, 10:25 AM4 days ago
SMA: BullishOct 30, 9:55 AM4 days ago
SMA: BullishOct 29, 3:55 PM4 days ago
MACD: Buy SignalOct 29, 3:25 PM4 days ago
MACD: Sell SignalOct 29, 2:55 PM4 days ago
RSI: OversoldOct 29, 2:55 PM4 days ago
SMA: BearishOct 29, 12:25 PM4 days ago
SMA: BullishOct 29, 9:55 AM5 days ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 115.48 +30.5% upside
Target (low)
103.00
Target (mean)
115.48
Target (high)
145.00
Ratings (0m) 27 25 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy18
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 27
  • 1 month ago 27
  • 2 months ago 27

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CVS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.651.52 – 1.871.60+3.2%104.69B+1.8%23
Next quarter1.241.08 – 1.361.09+14.1%106.86B+1.1%23
Current year8.047.94 – 8.156.75+19.1%417.87B+3.9%25
Next year8.548.43 – 9.058.04+6.1%430.08B+2.9%26

Upgrades and downgrades

The latest rating changes

CVS analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Leerink PartnersMaintainedOutperformOutperform
Sep 3, 2026UBSMaintainedBuyBuy
Aug 19, 2026Argus ResearchMaintainedBuyBuy
Aug 12, 2026JP MorganMaintainedOverweightOverweight
Aug 6, 2026UBSMaintainedBuyBuy
Aug 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Aug 6, 2026BarclaysMaintainedOverweightOverweight
Jul 24, 2026UBSMaintainedBuyBuy
Jul 14, 2026Truist SecuritiesMaintainedBuyBuy
Jul 13, 2026Wells FargoMaintainedOverweightOverweight
Jul 9, 2026RBC CapitalMaintainedOutperformOutperform
Jul 7, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Jun 23, 2026B of A SecuritiesMaintainedBuyBuy
Jun 8, 2026MizuhoMaintainedOutperformOutperform
Jun 4, 2026Morgan StanleyMaintainedOverweightOverweight
Jun 1, 2026Truist SecuritiesMaintainedBuyBuy
May 26, 2026BarclaysMaintainedOverweightOverweight
May 20, 2026MizuhoMaintainedOutperformOutperform
May 14, 2026Morgan StanleyMaintainedOverweightOverweight
May 13, 2026BernsteinMaintainedOutperformOutperform
May 12, 2026JP MorganMaintainedOverweightOverweight
May 11, 2026TD CowenMaintainedBuyBuy
May 8, 2026Wells FargoMaintainedOverweightOverweight
May 7, 2026UBSMaintainedBuyBuy
May 7, 2026RBC CapitalMaintainedOutperformOutperform
May 7, 2026BarclaysMaintainedOverweightOverweight
May 7, 2026Truist SecuritiesMaintainedBuyBuy
May 7, 2026Evercore ISI GroupMaintainedOutperformOutperform
Apr 15, 2026BairdMaintainedOutperformOutperform
Mar 31, 2026Piper SandlerMaintainedOverweightOverweight